Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
deals
investing
3
×
life sciences
national blog main
boston
boston blog main
fda
startups
achaogen
adams street partners
akouos
allosteric
antibiotics
astellas pharmaceuticals
atlas venture
atopic dermatitis
autoimmune disorders
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
boston top stories
brace pharma
california institute for biomedical research
cleva pharma
decibel therapeutics
drug discovery
drug resistance
drugs
dupilumab
frequency therapeutics
glaxosmithkline
harvard university
hatteras venture partners
hearing loss
hotspot therapeutics
jeffrey karp
jonathan montagu
lyzz capital
macrolide pharmaceuticals
What
medicines
3
×
therapeutics
3
×
disease
drug
address
adds
affects
ago
allosteric
americans
approved
bacteria
biopharma
business
clinic
company
date
developing
elusive
exited
fda
fighting
frequency
hearing
hotspot
infections
infectious
ipo
launches
loss
meds
melinta
millions
molecules
new
path
plans
potential
products
qpex
Language
unset
Current search:
medicines
×
investing
×
therapeutics
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
